Page last updated: 2024-08-07 15:54:40
DNA topoisomerase 1
A type 1B DNA topoisomerase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P11387]
Synonyms
EC 5.6.2.1;
DNA topoisomerase I
Research
Bioassay Publications (51)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 1 (1.96) | 18.7374 |
1990's | 15 (29.41) | 18.2507 |
2000's | 14 (27.45) | 29.6817 |
2010's | 13 (25.49) | 24.3611 |
2020's | 8 (15.69) | 2.80 |
Compounds (54)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
hoe 33342 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
bisbenzimidazole | Homo sapiens (human) | IC50 | 22.8600 | 1 | 1 |
LSM-1442 | Homo sapiens (human) | IC50 | 1.5000 | 2 | 2 |
stallimycin | Homo sapiens (human) | IC50 | 2.7000 | 1 | 1 |
juglone | Homo sapiens (human) | IC50 | 8.2600 | 1 | 1 |
netropsin | Homo sapiens (human) | IC50 | 62.0000 | 1 | 1 |
reserpine | Homo sapiens (human) | IC50 | 160.0000 | 1 | 1 |
yohimbine | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
camptothecin | Homo sapiens (human) | IC50 | 33.2563 | 21 | 22 |
bisbenzimidazole trihydrochloride | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
etoposide | Homo sapiens (human) | IC50 | 460.0000 | 2 | 3 |
topotecan hydrochloride | Homo sapiens (human) | IC50 | 1.0800 | 1 | 1 |
topotecan | Homo sapiens (human) | IC50 | 3.3000 | 9 | 9 |
9-aminocamptothecin | Homo sapiens (human) | IC50 | 0.1100 | 1 | 1 |
10,11-methylenedioxy-20-camptothecin | Homo sapiens (human) | IC50 | 0.0525 | 2 | 2 |
alpha-amyrin | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
corilagin | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
gallanilide | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
10-hydroxycamptothecin | Homo sapiens (human) | IC50 | 0.1100 | 1 | 1 |
sn 38 | Homo sapiens (human) | IC50 | 3.2500 | 2 | 2 |
7-ethyl-7-hydroxy-10h-1,3-dioxolo(4,5-g)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-8,11(7h,12h)-dione | Homo sapiens (human) | IC50 | 0.0525 | 2 | 2 |
ginsenoside re | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
Chebulagic acid | Homo sapiens (human) | IC50 | 0.0750 | 2 | 2 |
oleic acid | Homo sapiens (human) | IC50 | 31.0000 | 1 | 1 |
ganoderiol f | Homo sapiens (human) | IC50 | 106.0000 | 1 | 1 |
beta, beta-dimethylacrylshikonin, (+)-isomer | Homo sapiens (human) | IC50 | 77.0000 | 1 | 1 |
shikonin | Homo sapiens (human) | IC50 | 208.0000 | 1 | 1 |
elaidic acid | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
ungeremine | Homo sapiens (human) | IC50 | 6.1000 | 1 | 1 |
ginsenoside rb1 | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
ginsenoside f2 | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
ginsenoside rg3 | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
ginsenoside rd | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
ginsenoside rb3 | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
nsc 100880 | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
gypenoside XVII | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
(20R)-ginsenoside Rg3 | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
nsc 158393 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
Drugs with Activation Measurements
Drugs with Other Measurements
Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.Bioorganic & medicinal chemistry letters, , 06-01, Volume: 41, 2021
Inhibition of topoisomerase I by naphthoquinone derivatives.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 8, Issue:23, 1998
[no title available]Journal of medicinal chemistry, , 08-11, Volume: 65, Issue:15, 2022
Design, synthesis of DNA-interactive 4-thiazolidinone-based indolo-/pyrroloazepinone conjugates as potential cytotoxic and topoisomerase I inhibitors.European journal of medicinal chemistry, , Aug-05, Volume: 238, 2022
Copper(I)-Catalyzed Nitrile-Addition/Journal of medicinal chemistry, , 02-11, Volume: 64, Issue:3, 2021
Design, synthesis and screening of benzimidazole containing compounds with methoxylated aryl radicals as cytotoxic molecules on (HCT-116) colon cancer cells.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
Development of a metabolically stable topoisomerase I poison as anticancer agent.European journal of medicinal chemistry, , Sep-15, Volume: 202, 2020
Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone.European journal of medicinal chemistry, , Jun-15, Volume: 172, 2019
Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.Journal of medicinal chemistry, , 04-11, Volume: 62, Issue:7, 2019
Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazides.Journal of enzyme inhibition and medicinal chemistry, , Volume: 29, Issue:2, 2014
Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.Journal of medicinal chemistry, , Aug-26, Volume: 53, Issue:16, 2010
Syntheses and biological evaluation of topoisomerase I-targeting agents related to 11-[2-(N,N-dimethylamino)ethyl]-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-one (ARC-31).Bioorganic & medicinal chemistry, , Aug-15, Volume: 16, Issue:16, 2008
Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.Journal of medicinal chemistry, , May-18, Volume: 49, Issue:10, 2006
Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.Journal of medicinal chemistry, , Apr-07, Volume: 48, Issue:7, 2005
Indole alkaloids and other constituents of Rauwolfia serpentina.Journal of natural products, , Volume: 68, Issue:6, 2005
Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 14, Issue:21, 2004
Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.Journal of natural products, , Volume: 64, Issue:2, 2001
Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.Journal of medicinal chemistry, , Jan-17, Volume: 40, Issue:2, 1997
Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I.Journal of medicinal chemistry, , Feb-03, Volume: 38, Issue:3, 1995
Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs.Journal of medicinal chemistry, , Mar-31, Volume: 38, Issue:7, 1995
Acylshikonin analogues: synthesis and inhibition of DNA topoisomerase-I.Journal of medicinal chemistry, , Mar-17, Volume: 38, Issue:6, 1995
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.Journal of medicinal chemistry, , Nov-12, Volume: 36, Issue:23, 1993
Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.Journal of medicinal chemistry, , Sep-03, Volume: 36, Issue:18, 1993
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.Journal of medicinal chemistry, , Volume: 34, Issue:1, 1991
Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.Journal of medicinal chemistry, , Volume: 32, Issue:3, 1989
Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazides.Journal of enzyme inhibition and medicinal chemistry, , Volume: 29, Issue:2, 2014
Indole alkaloids and other constituents of Rauwolfia serpentina.Journal of natural products, , Volume: 68, Issue:6, 2005
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.Journal of medicinal chemistry, , Nov-12, Volume: 36, Issue:23, 1993
2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity.Journal of medicinal chemistry, , Aug-23, Volume: 50, Issue:17, 2007
N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation.European journal of medicinal chemistry, , Dec-15, Volume: 226, 2021
Development of a metabolically stable topoisomerase I poison as anticancer agent.European journal of medicinal chemistry, , Sep-15, Volume: 202, 2020
Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.Journal of medicinal chemistry, , 04-11, Volume: 62, Issue:7, 2019
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.European journal of medicinal chemistry, , Volume: 49, 2012
Inverse virtual screening of antitumor targets: pilot study on a small database of natural bioactive compounds.Journal of natural products, , Jun-24, Volume: 74, Issue:6, 2011
Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.Journal of medicinal chemistry, , Apr-07, Volume: 48, Issue:7, 2005
Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin.Journal of medicinal chemistry, , Feb-02, Volume: 39, Issue:3, 1996
Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I.Journal of medicinal chemistry, , Feb-03, Volume: 38, Issue:3, 1995
Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.Journal of medicinal chemistry, , Sep-03, Volume: 36, Issue:18, 1993
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.Journal of medicinal chemistry, , Volume: 34, Issue:1, 1991
Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 14, Issue:21, 2004
Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I.Journal of medicinal chemistry, , Feb-03, Volume: 38, Issue:3, 1995
Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.Journal of medicinal chemistry, , Sep-03, Volume: 36, Issue:18, 1993
Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent.Journal of medicinal chemistry, , Feb-25, Volume: 42, Issue:4, 1999
Synthesis, mode of action, and biological activities of rebeccamycin bromo derivatives.Journal of medicinal chemistry, , May-20, Volume: 42, Issue:10, 1999
Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.Journal of medicinal chemistry, , May-07, Volume: 41, Issue:10, 1998
Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.Journal of medicinal chemistry, , Oct-10, Volume: 40, Issue:21, 1997
Copper(I)-Catalyzed Nitrile-Addition/Journal of medicinal chemistry, , 02-11, Volume: 64, Issue:3, 2021
Synthesis of new camptothecin analogs with improved antitumor activities.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 19, Issue:7, 2009
Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 14, Issue:21, 2004
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.Journal of medicinal chemistry, , Volume: 34, Issue:1, 1991
Inhibition of topoisomerase I by naphthoquinone derivatives.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 8, Issue:23, 1998
Acylshikonin analogues: synthesis and inhibition of DNA topoisomerase-I.Journal of medicinal chemistry, , Mar-17, Volume: 38, Issue:6, 1995
Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.Bioorganic & medicinal chemistry, , 11-01, Volume: 24, Issue:21, 2016
Synthesis and biological activities of topoisomerase I inhibitors, 6-arylmethylamino analogues of edotecarin.Journal of medicinal chemistry, , May-28, Volume: 52, Issue:10, 2009
Synthesis and biological activities of NB-506 analogues modified at the glucose group.Bioorganic & medicinal chemistry letters, , Mar-06, Volume: 10, Issue:5, 2000
Enables
This protein enables 13 target(s):
Target | Category | Definition |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | molecular function | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. [GOC:txnOH-2018] |
DNA binding | molecular function | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). [GOC:dph, GOC:jl, GOC:tb, GOC:vw] |
chromatin binding | molecular function | Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. [GOC:jl, ISBN:0198506732, PMID:20404130] |
double-stranded DNA binding | molecular function | Binding to double-stranded DNA. [GOC:elh, GOC:vw] |
single-stranded DNA binding | molecular function | Binding to single-stranded DNA. [GOC:elh, GOC:vw, PMID:22976174] |
RNA binding | molecular function | Binding to an RNA molecule or a portion thereof. [GOC:jl, GOC:mah] |
DNA topoisomerase type I (single strand cut, ATP-independent) activity | molecular function | Catalysis of a DNA topological transformation by transiently cleaving one DNA strand at a time to allow passage of another strand; changes the linking number by +1 per catalytic cycle. [PMID:8811192] |
protein serine/threonine kinase activity | molecular function | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. [GOC:bf, MetaCyc:PROTEIN-KINASE-RXN, PMID:2956925] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
ATP binding | molecular function | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. [ISBN:0198506732] |
DNA binding, bending | molecular function | The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence. [GOC:krc, GOC:vw, PMID:10710711, PMID:19037758] |
protein domain specific binding | molecular function | Binding to a specific domain of a protein. [GOC:go_curators] |
supercoiled DNA binding | molecular function | Binding to supercoiled DNA. For example, during replication and transcription, template DNA is negatively supercoiled in the receding downstream DNA and positively supercoiled in the approaching downstream DNA. [GOC:pr, GOC:rph, PMID:20723754, PMID:21345933, Wikipedia:DNA_supercoil] |
Located In
This protein is located in 7 target(s):
Target | Category | Definition |
P-body | cellular component | A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing. [GOC:clt, PMID:12730603] |
fibrillar center | cellular component | A structure found most metazoan nucleoli, but not usually found in lower eukaryotes; surrounded by the dense fibrillar component; the zone of transcription from multiple copies of the pre-rRNA genes is in the border region between these two structures. [PMID:10754561] |
male germ cell nucleus | cellular component | The nucleus of a male germ cell, a reproductive cell in males. [CL:0000015, GOC:hjd, GOC:mtg_sensu] |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
nucleolus | cellular component | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. [ISBN:0198506732] |
perikaryon | cellular component | The portion of the cell soma (neuronal cell body) that excludes the nucleus. [GOC:jl] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
nucleolus | cellular component | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. [ISBN:0198506732] |
Part Of
This protein is part of 1 target(s):
Target | Category | Definition |
protein-DNA complex | cellular component | A macromolecular complex containing both protein and DNA molecules. [GOC:mah] |
Involved In
This protein is involved in 11 target(s):
Target | Category | Definition |
DNA topological change | biological process | The process in which a transformation is induced in the topological structure of a double-stranded DNA helix, resulting in a change in linking number. [ISBN:071673706X, ISBN:0935702490] |
chromatin remodeling | biological process | A dynamic process of chromatin reorganization resulting in changes to chromatin structure. These changes allow DNA metabolic processes such as transcriptional regulation, DNA recombination, DNA repair, and DNA replication. [GOC:jid, GOC:vw, PMID:12042764, PMID:12697820] |
circadian rhythm | biological process | Any biological process in an organism that recurs with a regularity of approximately 24 hours. [GOC:bf, GOC:go_curators] |
response to xenobiotic stimulus | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. [GOC:jl, GOC:krc] |
programmed cell death | biological process | A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell. [GOC:lr, GOC:mtg_apoptosis] |
phosphorylation | biological process | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. [ISBN:0198506732] |
peptidyl-serine phosphorylation | biological process | The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. [RESID:AA0037] |
circadian regulation of gene expression | biological process | Any process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours. [GOC:mah] |
embryonic cleavage | biological process | The first few specialized divisions of an activated animal egg. [GOC:clt, ISBN:0070524300] |
chromosome segregation | biological process | The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles. [GOC:jl, GOC:mah, GOC:mtg_cell_cycle, GOC:vw] |
DNA replication | biological process | The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by the origin recognition complex, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA. [GOC:mah] |